Suchergebnisse - "Cañete, Fiorella"

PubPharm (7)

1

Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease : The ADA-SWITCH study

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Casanova, M. | Nantes, �. | Varela, P. | +39

2

Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease : An ECCO CONFER Multicentre Case Series

enthalten in: Journal of Crohn's & colitis | 2023

von Ribaldone, D. | Vieujean, S. | Julsgaard, M. | +12

3

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease : A Nationwide Study With Propensity-Matched Score Analysis

enthalten in: Clinical and translational gastroenterology | 2020

von Cañete, F. | Mañosa, M. | Pérez-Martínez, I. | +23

4

Spacing the Administration Interval of Anti-TNF Agents : A Valid Strategy for Patients with Inflammatory Bowel Disease?

enthalten in: Digestive diseases and sciences | 2020

von Torres, P. | Cañete, F. | Núñez, L. | +8

CommentIn: Dig Dis Sci. 2020 Jul;65(7):2044-2045. - PMID 32016822

5

Impact of pain associated with the subcutaneous administration of adalimumab

enthalten in: Gastroenterologia y hepatologia | 2020

von Gely, C. | Marín, L. | Gordillo, J. | +7

6

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease : Results From the ENEIDA Registry

enthalten in: Inflammatory bowel diseases | 2019

von Cañete, F. | Mañosa, M. | Casanova, M. | +32

7

Granulocyte-monocyte apheresis : an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis

enthalten in: Scandinavian journal of gastroenterology | 2019

von Rodríguez-Lago, I. | Sempere, L. | Gutiérrez, A. | +15

1
[1]